Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed

Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis

(2017) L. Calzetta et al.   EQUINE VETERINARY JOURNAL

Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control

(2016) Glenn A. Jacobson et al.   Drug Testing and Analysis

Equine asthma: An appropriate, translational and comprehendible terminology?

(2016) R. S. Pirie et al.   EQUINE VETERINARY JOURNAL

Deaths from childhood asthma, 2004–2013: what lessons can we learn?

(2015) Peter van Asperen   MEDICAL JOURNAL OF AUSTRALIA

One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD

(2014) James F. Donohue et al.   CHEST

Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications

(2014) C Guillemette et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?

(2014) Barbara Osimani et al.   DRUG SAFETY

SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: Are some athletes at risk of higher urine levels?

(2014) Glenn A Jacobson et al.   Drug Testing and Analysis

Albuterol Administration Is Commonly Associated With Increases in Serum Lactate in Patients With Asthma Treated for Acute Exacerbation of Asthma

(2013) Lawrence M. Lewis et al.   CHEST

Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle

(2013) Glenn A. Jacobson et al.   Drug Testing and Analysis

Chiral Switch Drugs for Asthma and Allergies: True Benefit or Marketing Hype

(2013) Kathryn Blake et al.   Pediatric Allergy Immunology and Pulmonology

Salbutamol tolerance to bronchoprotection: course of onset

(2012) Sarah L. Stewart et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants

(2012) Ali A Alkhafaji et al.   BMC Medicine

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Levalbuterol versus albuterol for acute asthma: A systematic review and meta-analysis

(2012) Kana Ram Jat et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?

(2012) Malcolm R Sears   THORAX

Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi

(2011) Luigino Calzetta et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms

(2011) PR Cooper et al.   BRITISH JOURNAL OF PHARMACOLOGY

A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma

(2011) J. Hinkle et al.   PEDIATRIC PULMONOLOGY

Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi

(2011) Maria G. Matera et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Heaves, an asthma-like disease of horses

(2011) MATHILDE LECLERE et al.   RESPIROLOGY

The Safety and Efficacy of Arformoterol and Formoterol in COPD

(2010) Nicola A. Hanania et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach

(2010) Panayiotis A. Procopiou et al.   JOURNAL OF MEDICINAL CHEMISTRY

The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma

(2010) Badrul A. Chowdhury et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD

(2009) D.P. Tashkin et al.   RESPIRATORY MEDICINE

Chiral Toxicology: It's the Same Thing…Only Different

(2009) Silas W. Smith   TOXICOLOGICAL SCIENCES

Effect of Nebulized Arformoterol on Airway Function in COPD: Results from Two Randomized Trials

(2008) John P. Hanrahan et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD)

(2008) John P. Hanrahan et al.   MEDICINE

A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease

(2008) J. Kharidia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance

(2008) J.F. Donohue et al.   Therapeutic Advances in Respiratory Disease